A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma.

MLA

Teknos, Theodoros N., et al. “A Phase 1 Trial of Vorinostat in Combination with Concurrent Chemoradiation Therapy in the Treatment of Advanced Staged Head and Neck Squamous Cell Carcinoma.” Investigational New Drugs, vol. 37, no. 4, Aug. 2019, pp. 702–10. EBSCOhost, https://doi.org/10.1007/s10637-018-0696-4.

APA

Teknos, T. N., Grecula, J., Agrawal, A., Old, M. O., Ozer, E., Carrau, R., Kang, S., Rocco, J., Blakaj, D., Diavolitsis, V., Kumar, B., Kumar, P., Pan, Q., Palettas, M., Wei, L., Baiocchi, R., & Savvides, P. (2019). A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma. Investigational New Drugs, 37(4), 702–710. https://doi.org/10.1007/s10637-018-0696-4

Chicago

Teknos, Theodoros N., J. Grecula, A. Agrawal, M. O. Old, E. Ozer, R. Carrau, S. Kang, et al. 2019. “A Phase 1 Trial of Vorinostat in Combination with Concurrent Chemoradiation Therapy in the Treatment of Advanced Staged Head and Neck Squamous Cell Carcinoma.” Investigational New Drugs 37 (4): 702–10. doi:10.1007/s10637-018-0696-4.